Solvent bar microextraction combined with HPLC-UV was used for the detection and determination of Cyproheptadine in biological samples.Cyproheptadine is used to treat allergic reactions. Extraction parameters including organic solvent, pH of sample solution and acceptor phase, extraction time, stirring rate, salt addition and sample solution temperature were optimized. The target analyte were extracted from a 10 mL aqueous sample solution at pH 10.5 through a membrane organic solvent immobilized in polypropylene hollow fiber pores to 10 µL acceptor phase at pH 3.0 in the lumen of hollow fiber. After a 50 min extraction, the acceptor phase was directly injected into an HPLC system for analysis. Under the optimized conditions, cyproheptadine could be determined within the linearity range with a good correlation coefficient (r 2 > 0.9885). The limit of detection for cyproheptadine was 15µg L -1 , and the intra-and inter-day relative standard deviations were no more than 3.15% and 3.57%, respectively. This procedure afforded a simple, sensitive and inexpensive method with high extraction efficiency for the detection and determination of cyproheptadine. Finally, proposed method was applied to determination and quantification of cyproheptadine in human plasma and urine samples.
Cyproheptadine is used to treat allergic reactions [1] [2] [3] . The chemical structure, IUPAC name, the octanol-water distribution coefficient, and acidity constant of the target drugareclassified in Table 1 4 .Cyproheptadine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes and/or nose, sneezing, hives, and itching. It works by blocking a certain natural substance such as histamine that the human body makes during an allergic reaction. This medication also blocks another natural substance in the body, such as serotonin [5] [6] [7] .This medication should not be used in newborn or premature infants. Along with their useful effects, most medicines can cause unwanted side-effects, although not everyone experiences them 8, 9 . Blurred vision, constipation, dizziness, drowsiness, dry mouth, throat, or nose, excitability, nausea and nervousnessmay occur the first few days as you took the medication.
Several methods have been presented for detection and determination of cyproheptadine until now.Numerous articles have been published on the detection and determination of cyproheptadine in different matrices. Most of them concern with high-performance liquid chromatography(HPLC) [10] [11] [12] [13] [14] [15] , Liquid chromatography-mass spectrometry 16 , gas chromatography (GC) 17, 18 , chemiluminescence system 19 and electrochemistry techniques [20] [21] [22] [23] .
Today, there is a constant need for the development of simple, fast,sensitive and more selective sample preparation systems. To best of our knowledge,only one microextractionmethod hasbeen presented for extraction and enrichment of cyproheptadine from biological fluids 10 . The major aim of this study is the development of a simple, sensitive, selective and fast analysis method, which allows the analysis of cyproheptadine in biological fluids. For the first time, in current study, solvent barmicroextraction (SBME) technique combined with HPLC with ultraviolet (UV) detection was optimized and validated for detection and determination ofcyproheptadine in biological samples.
A new technique of LPME, SBME was reported by Jiang and Leein 2004 [24] . In SBME, target analytes are extracted from an aqueous sample, into the membrane organic solvent immobilized as a SLM in hollow fiber wall pores, and into the acceptor solution placed inside the lumen of the hollow fiber 25 . Generally, SBME presents better extraction efficiency, sensitivity,selectivity and extraction time compared to other LPME methods.Today, SBMEhas two modes. Both of the membrane organic solvent immobilized in the ûber pores and the acceptor phase are samein two-phase SBME [26] [27] [28] but,in three-phase SBME,the analytes are extracted from the aqueous sample solution to the organic solvent immobilized in the ûber pores, and then into another aqueous phase inside the lumen of hollow fiber [29] [30] [31] [32] [33] [34] . Compared with two-phase SBME, threephase extraction has a much cleanup and selectivity.
In this study, we describe a one-step microextractionmethod fordetection, extraction, and preconcentration of cyproheptadine in plasma samples. The factors, which influenced the extraction, such as membrane organic solvent, sample solution and acceptor phase pH, extraction time, stirring rate, and salt addition effect, are discussed and optimized to the determination of the target analyte in real sample.
EXPERIMENTAL

Reagents and reference standards
Cyproheptadinestandard, kindlydonated by Drug and Food Administration (Tehran, Iran).Reagent grade 1-Octanol, dodecanol, isobutylmethyl ketone, n-hexane,and n-heptane were purchased from Merck (Darmstadt, Germany). HPLC grade acetonitrile and Methanol were from Sigma-Aldrich (St. Louis, MO, USA).Sodium hydroxide, sodium chloride, and orthophosphoric acid were purchased from Sigma-Aldrich. Ultra pure water was purified with a MilliQ apparatus by Millipore (Madrid, Spain), and used in the HPLC mobile phase and preparation of all sample solutions.
PPQ3/2 polypropylene hollow fiber was used in the extraction process from Membrana (Wuppertal, Germany) with the inner diameter of 0.6 mm, wall thickness of 200 µm, and pore size of 0.2 µm.
A 100 mg L "1 stock solution of cyproheptadine was prepared in the mobile phase. The stock solutions were stable for at least three months when stored at -4 °C. Daily standard solutions were prepared by diluting the stock solutions in pure water.
HPLC conditions
The HPLC system consisted of a Younglin YL9100 HPLC (Seoul, Korea) equipped witha Quaternary9110 HPLC pump (Seoul, Korea), a 4-channel mixing valve with a 10 µL sample loop, YL9101 vacuum degasser and a YL 9120 UV-Vis detector. Chromatographic data were recorded and analyzed using Younglin Auto Chro 3000 software.An ODS-3 column (150 mm × 4.6 mm, with particle size of 5 µm) from MZ-Analysentechnik (Mainz, Germany) was used for separatin.The mobile phase was a 20 mM sodium dihydrogen phosphate-acetonitrile solution (40:60). The flow rate of the mobile phase was set at 1.0 mL min -1 under isocratic condition. Total analysis time was 14 min.The injection volume was 10 µL for all of the samples and UV detection wavelength was set at 230 nm.
Sample solutions were stirred using a MR Hei-standard magnetic stirrer from Heidolph(Schwabach, Germany). Sample solution and acceptor phase pH were adjusted by means ofGPHR 1400 digital pH meter from Greisinger (Regenstauf, Germany).
Extraction procedure
Extractions were performed according to the following procedure: A new 40mm length of hollow ûber was cut and washed with acetone in an ultrasonic bath for 10 min and dried at room temperature. Then, 100 ìL Hamilton syringe stuffed full of acceptor solution and the tip of the Hamilton syringe was inserted into the lumen of the treated hollow fiber from one end. The fiber was then dipped in the membrane organic solvent (1-octanol) for 10 s to impregnate the pores of the hollow fiber wall, and then inserted the hollow fiber into the water for 3 s to wash the excess organic solvent from the hollow fiber walls. Then, the acceptor solution from the Hamilton syringe was filled into the lumen of the hollow fiber. First, 40 ìL of acceptor solution was flushed out of the fiber in order to remove any organic solvent remaining inside the lumen of hollow fiber, and then 10 ìL acceptor solution was remained in the lumen of hollow fiber. The upper and the lower end of the hollow fiber were mechanically sealed with two-piece of aluminum foil. For each experiment, 10mL of the donor solution was transferred into the 50 mL sample vial, followed by a stirring bar. The fiber was dipped into the sample solution and extraction was performed for a 50 min. During extraction, the solution was stirred at 500 rpm. After extraction, the 10 ìL acceptor phase was withdrawn into the microsyringe and collected into the micro-vial and ûnally, acceptor solution was injected into the HPLC instrument.
Real sample analysis
Drug-free human plasma was obtained from the Iranian Blood Transfusion Organization (Tehran, Iran). Urine samples were collected from healthy young volunteer. The samples were stored at "4ÚCuntil required. The frozen urine sample was thawed and shaken at room temperature before use.
Calculation of preconcentrationfactor, and relative recovery
The analytepreconcentration factor (PF) is calculated by the following formula:
... (1) where C s, final is the final analyte concentration in the acceptor phase, and C o, initial is the initial analyte concentration within the sample. Relative recovery (RR) was calculated by the following equation:
... (2) where C found , C real , and C added are the concentrations of the analyts after addition of known amounts of the standard into the real sample, the concentration of analyte in real sample, and the concentration of known amounts of the standard which was spiked into the real sample, respectively.
RESULTS AND DISCUSSION
Choice of the organic solvent
The nature of membrane organic solvent immobilized in the pores of the hollow ûber is a substantial role for extraction and preconcentration of target analyte [35] . In this work, five types of membrane organic solvent including 1-octanol, 1-dodecanol, isobutyl methyl ketone, n-hexane, and n-heptanewere investigated for use in SBME. As shown in Fig. 1A , the highest extraction efficiency was obtained with 1-octanol. Therefore, 1-octanol was selected as the immobilization membrane organic solvent for subsequent experiments. Composition of sample solution and acceptor phase for SBME
In the three phases SBME, the pH of the sample solution and the acceptor phase play very important roles. Generally, in three-phase LPME,analytes are extracted from an aqueous sample solution, through the membrane organic solvent, and into an aqueous acceptor phase. For the extraction of basic compounds, the sample solution pH was adjusted into the basic region to suppress analyte solubility, whereas the pH in the acceptor solution was adjusted into the acidic region to promote analyte solubility. In the threephase SBME, a protonation process was applied to increment extraction. In the basicsample solution, the target analytes were deionized to their neutral form, which caused their solubility to decrease in the sample solution. In the acidic acceptor phase, the target analytes were in its ionic form, which caused its solubility to increase in the acceptor phase.Therefore, experiments were conducted to optimize the pH of both the sample solution and the acceptor phase. For this reason, donor sample pH was studied in the basic pH from 9 to 12. As shown in Fig. 1B , the highest extraction efficiency for cyproheptadine was obtained using pH=10.5. Therefore, pH=10.5 was used for all further experiments. The pH of acceptor phase was studiedfrom 2 to 5. As shown in Fig. 1C , the highest extraction efficiency was obtained at pH=3.0. Therefore, pH=3.0 was used for all further experiments.
Effect of stirring rate
Sample solution stirring enhances extraction efficiency and reduces the extraction time required to reach equilibrium. Sample solution stirring also facilitates the transfer of target analyte from donor solution to acceptor phase and improves the extraction efficiency. In this study, the stirring rates ranging from 100 to 1000 rpm were investigated. The extraction efficiency was highest at 500 rpm (Fig. 1D) . Hence, 500 rpm was selected as a sample solution stirring rate for further optimization. At higher stirring rate, extraction efficiency decreased because the immobilized membrane organic solvent was removed from the hollow ûber wall pores.
Effect of salt addition to the sample solution
Salt addition could enhance the extraction efûciency due to salting-out effect. In some instances, the high concentration of salt changed the physical properties of the Nernst diffusion ûlm and increased the aqueous solution viscosity, which lead to difficult mass transfer and decrease extraction efficiency. Thus, NaCl was added at concentration of 0% to 20% (w/v) of the sample solution and results are shown in Fig. 2A . The extraction efficiency, decreased when the NaCl concentration was increased from 0 to 20% (w/v). Therefore, extraction without salt addition was chosen as optimal condition, and used for all further experiments.
Effect of extraction time
Thus, the effect of the extraction time was studied from 10 to 60 min. The result in Fig. 2B showed that up to 50 min, the extraction efficiency rapidly increased. The mass transfer is a timedependent process. Thus, extraction efficiency of target analyte increased with extraction time. However, when the extraction time was longer than 50 min, the extraction efficiency slightly decreased due to membrane organic solvent instability and dissolution in the sample solution. Therefore, an extraction time of 50 min was selected as the extraction time in all further experiments.
Effect of extraction temperature
The sample solution temperature plays very important roles in the three phases SBME. The effect of temperature on the extraction efficiency of cyproheptadine was examined over a temperature range of 25 to 50 °C and result is shown in Fig. 2C .Increasing of temperature from 25 to 35 °C increase extraction efficiency.Increasing extraction temperature accelerates the mass transfer rates of analytes and increase extraction efficiency. But when the extraction temperature increased over than 35 °C, significant decrease in extraction efficiency was observed. Therefore, all further experiments were performed in35 ºC as a sample solution temperature.
Method evaluation
Under the optimized conditions, a series of experiments were performed to determine the linear ranges, preconcentration factor, and LODs of the proposed method. As shown in Table 2 . The preconcentration factor were 105-fold and the relative standard deviations (RSDs) were less than 3.15% and 3.57% for intraday and interday experiment, respectively.
Real samples analysis
The applicability of the proposed method was evaluated by analysis of two biological real samples, human urine and human plasma. In order to reduce matrix effects, calibration curves were plotted in drug free biological samples. Drug-free human urine and plasma samples was a diluted before SBME (1:4) with ultra pure water and added the proper amount of NaOH solution to achieve pH of sample solution to 10.5 The analytical results were shown in Table 3 . In both of the two samples, target analyte was below their detection limits, so . The relative recoveries were calculated by the concentration found to that spiked. Table 3 showed that the relative recoveries were in the range of 87.5 and 91.5%. The typical chromatograms were shown in Fig. 3 .
Comparison of the proposed method with other methods
Comparison of the proposed method with various extraction methods for extraction and determination of cyproheptadine is summarized in Table 4 . It is shown that, the proposed method provided good linearity range, high extraction efficiency, and a suitable sensitivity.
Concluding remarks
In this work, a new and fast analytical method based on SBME coupled with high performance liquid chromatography has been developed. Application of this method to the detection and determination of cyproheptadine in urine and plasma samples.An effective sample cleanup with a high preconcentration factor and extraction efficiency were obtained, as well as good linearity. The advantages of this method will allow its facility application to the analysis of low concentration levels of cyproheptadine in urine and plasma samples. 
